CDT Equity Partners With QIMA Life Sciences On Autoimmune Skin Research, Shares Fall In Pre-market
(RTTNews) - US biotech group CDT Equity Inc. (CDT), announced on Friday that it has entered into a partnership with French contract research organization QIMA Life Sciences to explore the potential of several CDT assets in autoimmune skin diseases.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.